Clinical Trial Update: Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy

View source ↗

Summary

A completed study evaluating the efficacy of continuous glucose monitoring (CGM) in people with Type 1 diabetes treated with multiple daily injections or insuli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Dexcom CGM

Snippet

Sponsor: DexCom, Inc. | Conditions: Type 1 Diabetes Mellitus | Status: COMPLETED